Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin

Bioorganic & Medicinal Chemistry
2009.0

Abstract

Human acidic mammalian chitinase (hAMCase) is an attractive target for developing anti-asthma medications. We used a variety of computational methods to investigate the interaction between hAMCase and the natural-product cyclopentapeptide chitinase inhibitor argifin. The three-dimensional structure of hAMCase was first constructed using homology modeling. The interaction mode and binding free energy between argifin and hAMCase were then examined by the molecular-docking calculation and the molecular mechanics Poisson-Boltzmann surface area method combined with molecular dynamics simulation, respectively. The results suggested that argifin binds to hAMCase in a similar fashion to the interaction mode observed in the crystal structure of argifin-human chitotriosidase complex, and possesses inhibitory activity against hAMCase in the micromolar range. We further designed argifin derivatives expected to be selective for hAMCase.

Knowledge Graph

Similar Paper

Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin
Bioorganic & Medicinal Chemistry 2009.0
Computational analysis of the binding affinities of the natural-product cyclopentapeptides argifin and argadin to chitinase B from Serratia marcescens
Bioorganic & Medicinal Chemistry 2008.0
Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens
Bioorganic & Medicinal Chemistry Letters 2009.0
NMR spectroscopy and computational analysis of interaction between Serratia marcescens chitinase B and a dipeptide derived from natural-product cyclopentapeptide chitinase inhibitor argifin
Bioorganic & Medicinal Chemistry 2010.0
An efficient synthesis of argifin: A natural product chitinase inhibitor with chemotherapeutic potential
Bioorganic & Medicinal Chemistry Letters 2005.0
Creation of Customized Bioactivity within a 14-Membered Macrolide Scaffold: Design, Synthesis, and Biological Evaluation Using a Family-18 Chitinase
Journal of Medicinal Chemistry 2015.0
Argifin, a New Chitinase Inhibitor, Produced by Gliocladium sp. FTD-0668. II. Isolation, Physico-chemical Properties, and Structure Elucidation.
The Journal of Antibiotics 2000.0
Argifin; efficient solid phase total synthesis and evalution of analogues of acyclic peptide
Bioorganic & Medicinal Chemistry 2009.0
Structure-Based Exploration of Cyclic Dipeptide Chitinase Inhibitors
Journal of Medicinal Chemistry 2004.0
Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE–ligand interactions by docking calculations and molecular dynamics simulations
European Journal of Medicinal Chemistry 2014.0